Maria C Carrillo
Biographic Data
| ID | 10720792 |
|---|---|
| NAME | Maria C Carrillo |
| GIVEN NAMES | Maria C |
| FAMILY NAME | Carrillo |
| SIGNATURE | CARRILLO M C |
| AFFILIATIONS | Alzheimer's Association Chicago IL USA |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2018 |
| H-INDEX | 0 |
NIA‐AA Research Framework
Summary of the evidence on modifiable risk factors for cognitive decline and dementia
The diagnosis of mild cognitive impairment due to Alzheimer's disease
The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's disease (AD), referred to in this article as mild cognitive impairment due to AD. The workgroup developed the following two sets of criteria: (1) core clinical criteria that could be used by healthcare providers without access to advanced imaging techniques or cerebrospinal f…
The diagnosis of dementia due to Alzheimer's disease
The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or i…
Toward defining the preclinical stages of Alzheimer's disease
The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the diagnosis of AD dementia. This long “preclinical” phase of AD would provide a critical opportunity for therapeutic intervention; however, we need to further elucidate the link between the pathological cascade of AD and the emergence of clinical symptoms. The National Institute on Aging and the Alzheimer's Association convened an international work…
No prominent works on this page.
The diagnosis of mild cognitive impairment due to Alzheimer's disease
The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's disease (AD), referred to in this article as mild cognitive impairment due to AD. The workgroup developed the following two sets of criteria: (1) core clinical criteria that could be used by healthcare providers without access to advanced imaging techniques or cerebrospinal f…
The diagnosis of dementia due to Alzheimer's disease
The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or i…
Toward defining the preclinical stages of Alzheimer's disease
The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the diagnosis of AD dementia. This long “preclinical” phase of AD would provide a critical opportunity for therapeutic intervention; however, we need to further elucidate the link between the pathological cascade of AD and the emergence of clinical symptoms. The National Institute on Aging and the Alzheimer's Association convened an international work…
Summary of the evidence on modifiable risk factors for cognitive decline and dementia
NIA‐AA Research Framework
Dementia and Cognitive Impairment Research (5 works) · Disease (5 works) · Medicine (5 works) · Psychology (5 works) · Alzheimer's disease (4 works) · Alzheimer's disease research and treatments (4 works) · Dementia (4 works) · Psychiatry (4 works) · Cognition (3 works) · Pathology (3 works)